{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:35:58Z","timestamp":1791466558970,"version":"4.3.4"},"update-to":[{"DOI":"10.1002\/14651858.cd010145","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000}}],"reference-count":145,"publisher":"Wiley","issue":"4","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010145.pub2","type":"journal-article","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T06:46:12Z","timestamp":1745995572000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Melatonin in cancer treatment"],"prefix":"10.1002","volume":"2025","author":[{"given":"Ze Yu","family":"Yu","sequence":"additional","affiliation":[{"name":"Centre for Evidence-Based Chinese Medicine; Beijing University of Chinese Medicine; Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong Yan","family":"Peng","sequence":"additional","affiliation":[{"name":"Dongzhimen Hospital, Beijing University of Chinese Medicine; Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuo","family":"Cheng","sequence":"additional","affiliation":[{"name":"Centre for Evidence-Based Chinese Medicine; Beijing University of Chinese Medicine; Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui Ting","family":"Wang","sequence":"additional","affiliation":[{"name":"Dongzhimen Hospital; Beijing University of Chinese Medicine; Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng Die","family":"Nan","sequence":"additional","affiliation":[{"name":"Dongzhimen Hospital, Beijing University of Chinese Medicine; Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Milazzo","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Oncology and Hematology; Paracelsus Medical University, Klinikum Nuremberg; Nuremberg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Pilkington","sequence":"additional","affiliation":[{"name":"School of Dental, Health and Care Professions; University of Portsmouth; Portsmouth UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dugald","family":"Seely","sequence":"additional","affiliation":[{"name":"The Patterson Institute for Integrative Oncology Research at CCNM (Canadian College of Naturopathic Medicine); Ottawa Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Horneber","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Respiratory Medicine; Paracelsus Medical University, Klinikum Nuernberg; Nuernberg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian Ping","family":"Liu","sequence":"additional","affiliation":[{"name":"Centre for Evidence-Based Chinese Medicine; Beijing University of Chinese Medicine; Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"key":"10.1002\/14651858.CD010145.pub2-BIB0001|cit1","unstructured":"World Health Organization. Cancer fact sheet. March 2021 https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cancer"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0002|cit2","unstructured":"World Health Organization Health topics: Cancer https:\/\/www.who.int\/health-topics\/cancer#tab=tab_1"},{"issue":"4","key":"10.1002\/14651858.CD010145.pub2-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1001\/jamaoncol.2022.7826","article-title":"Estimates and projections of the global economic cost of 29 cancers in 204 countries and territories from 2020 to 2050","volume":"9","author":"Chen","year":"2023","journal-title":"JAMA Oncology"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0004|cit4","unstructured":"World Health Organization Media Team Global cancer burden growing, amidst mounting need for services https:\/\/www.who.int\/news\/item\/01-02-2024-global-cancer-burden-growing--amidst-mounting-need-for-services"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0005|cit5","unstructured":"International Agency for Research on Cancer's Global Cancer Observatory https:\/\/gco.iarc.fr\/en"},{"issue":"3","key":"10.1002\/14651858.CD010145.pub2-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA: a Cancer Journal for Clinicians"},{"issue":"21","key":"10.1002\/14651858.CD010145.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"11696","DOI":"10.3390\/ijerph182111696","article-title":"Sleep disorders in cancer-a systematic review","volume":"18","author":"B\u00fcttner-Teleag\u0103","year":"2021","journal-title":"International Journal of Environmental Research and Public Health"},{"issue":"14","key":"10.1002\/14651858.CD010145.pub2-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.3390\/nu15143145","article-title":"The lived experience of young adult cancer survivors after treatment: a qualitative study","volume":"15","author":"Crowder","year":"2023","journal-title":"Nutrients"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s11912-021-01049-3","article-title":"Psychological aspects to consider in breast cancer diagnosis and treatment","volume":"23","author":"Loredana","year":"2021","journal-title":"Current Oncology Reports"},{"issue":"17","key":"10.1002\/14651858.CD010145.pub2-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1002\/cncr.28188","article-title":"Sleep disturbance, distress, and quality of life in ovarian cancer patients during the first year after diagnosis","volume":"119","author":"Clevenger","year":"2013","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"101293","DOI":"10.1016\/j.gore.2023.101293","article-title":"Health state utility and health-related quality of life measures in patients with advanced ovarian cancer","volume":"50","author":"Van Stein","year":"2023","journal-title":"Gynecologic Oncology Reports"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0012|cit12","unstructured":"National Cancer Institute Choices for care when treatment may not be an option https:\/\/www.cancer.gov\/about-cancer\/advanced-cancer\/care-choices"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1021\/ja01543a060","article-title":"Isolation of melatonin, the pineal gland factor that lightens melanocytes","volume":"80","author":"Lerner","year":"1958","journal-title":"Journal of the American Chemical Society"},{"issue":"3","key":"10.1002\/14651858.CD010145.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1734-1140(09)70081-7","article-title":"Physiology and pharmacology of melatonin in relation to biological rhythms","volume":"61","author":"Zawilska","year":"2009","journal-title":"Pharmacological Reports"},{"issue":"1","key":"10.1002\/14651858.CD010145.pub2-BIB0015|cit15","first-page":"1","article-title":"Melatonergic drugs in clinical practice","volume":"58","author":"Hardeland","year":"2008","journal-title":"Arzneimittel-Forschung"},{"issue":"6","key":"10.1002\/14651858.CD010145.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/bjp.2008.184","article-title":"Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new?","volume":"154","author":"Jockers","year":"2008","journal-title":"British Journal of Pharmacology"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.bbr.2013.01.008","article-title":"Sleep-wake characterization of double MT1\/MT2 receptor knockout mice and comparison with MT1 and MT2 receptor knockout mice","volume":"243","author":"Stefano","year":"2013","journal-title":"Behavioural Brain Research"},{"issue":"10","key":"10.1002\/14651858.CD010145.pub2-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.5664\/jcsm.5100PubMed","article-title":"Clinical practice guideline for the treatment of intrinsic circadian rhythm sleep-wake disorders: advanced sleep-wake phase disorder (ASWPD), delayed sleep-wake phase disorder (DSWPD), non-24-hour sleep-wake rhythm disorder (N24SWD), and irregular sleep-wake rhythm disorder (ISWRD): an update for 2015: an American Academy of Sleep Medicine clinical practice guideline","volume":"11","author":"Auger","year":"2015","journal-title":"Journal of Clinical Sleep Medicine"},{"issue":"2","key":"10.1002\/14651858.CD010145.pub2-BIB0019|cit19","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001520","article-title":"Melatonin for the prevention and treatment of jet lag","author":"Herxheimer","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0079-6123(08)81008-4","article-title":"Melatonin: a multitasking molecule","volume":"181","author":"Reiter","year":"2010","journal-title":"Progress in Brain Research"},{"issue":"2","key":"10.1002\/14651858.CD010145.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2174\/1568026023394443","article-title":"Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger","volume":"2","author":"Tan","year":"2002","journal-title":"Current Topics in Medicinal Chemistry"},{"issue":"3","key":"10.1002\/14651858.CD010145.pub2-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"532","DOI":"10.3390\/antiox11030532","article-title":"Melatonin and related compounds: antioxidant and anti-inflammatory actions","volume":"11","author":"Bantounou","year":"2022","journal-title":"Antioxidants"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"7638842","DOI":"10.1155\/2023\/7638842","article-title":"Melatonin promotes bmscs osteoblastic differentiation and relieves inflammation by suppressing the NF-\u03baB pathways","volume":"2023","author":"Hu","year":"2023","journal-title":"Stem Cells International"},{"issue":"1","key":"10.1002\/14651858.CD010145.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1600-079X.2009.00729.x","article-title":"Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer","volume":"48","author":"Jung-Hynes","year":"2010","journal-title":"Journal of Pineal Research"},{"issue":"2","key":"10.1002\/14651858.CD010145.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.intimp.2011.12.012","article-title":"Involvement of melatonin in autophagy-mediated mouse hepatoma H22 cell survival","volume":"12","author":"Liu","year":"2012","journal-title":"International Immunopharmacology"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"112279","DOI":"10.1016\/j.mce.2024.112279","article-title":"Melatonin improves nitric oxide bioavailability in isoproterenol induced myocardial injury","volume":"591","author":"Santos","year":"2024","journal-title":"Molecular and Cellular Endocrinology"},{"issue":"2","key":"10.1002\/14651858.CD010145.pub2-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3390\/biom14020145","article-title":"Unveiling the protective role of melatonin in osteosarcoma: current knowledge and limitations","volume":"14","author":"Nojoud","year":"2024","journal-title":"Biomolecules"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"18 (2018)","DOI":"10.1186\/s12916-017-1000-8","article-title":"Melatonin and health: an umbrella review of health outcomes and biological mechanisms of action","volume":"16","author":"Posadzki","year":"2018","journal-title":"BMC Medicine"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0029|cit29","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-13-1756-9_19","volume-title":"Advances in Pain Research: Mechanisms and Modulation of Chronic Pain. Advances in Experimental Medicine and Biology","volume":"1099","author":"Kaur","year":"2018"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.brainresbull.2021.06.010","article-title":"Melatonin ameliorates anxiety-like behaviors induced by sleep deprivation in mice: role of oxidative stress, neuroinflammation, autophagy and apoptosis","volume":"174","author":"Wang","year":"2021","journal-title":"Brain Research Bulletin"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"109953","DOI":"10.1016\/j.radphyschem.2021.109953","article-title":"Radioprotective effects of melatonin against varying dose rates on radiotherapy-induced salivary gland damage scintigraphy findings","volume":"193","author":"Serhat","year":"2022","journal-title":"Radiation Physics and Chemistry (Oxford, England: 1993)"},{"issue":"24","key":"10.1002\/14651858.CD010145.pub2-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"31108","DOI":"10.1007\/s11356-021-12951-5","article-title":"Melatonin exerts a neuroprotective effect against \u03b3-radiation-induced brain injury in the rat through the modulation of neurotransmitters, inflammatory cytokines, oxidative stress, and apoptosis","volume":"28","author":"El-Missiry","year":"2021","journal-title":"Environmental Science and Pollution Research International"},{"issue":"6","key":"10.1002\/14651858.CD010145.pub2-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"770","DOI":"10.14235\/bas.galenos.2022.70783","article-title":"Ramelteon protects intestinal tissue against injury caused by methotrexate via showing anti-apoptotic, antiinflammatory and antioxidant properties","volume":"10","author":"Catakli","year":"2022","journal-title":"Bezmialem Science"},{"issue":"3","key":"10.1002\/14651858.CD010145.pub2-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/jpi.12358","article-title":"Melatonin-induced increase in sensitivity of human hepatocellular carcinoma cells to sorafenib is associated with reactive oxygen species production and mitophagy","volume":"61","author":"Prieto-Dom\u00ednguez","year":"2016","journal-title":"Journal of Pineal Research"},{"issue":"1","key":"10.1002\/14651858.CD010145.pub2-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/bjc.2013.285","article-title":"Inhibition of VEGF expression through blockade of Hif1\u221d and STAT3 signalling mediates the anti-angiogenic effect of melatonin in HepG2 liver cancer cells","volume":"109","author":"Carbajo-Pescador","year":"2013","journal-title":"British Journal of Cancer"},{"issue":"37","key":"10.1002\/14651858.CD010145.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"38294","DOI":"10.1074\/jbc.M403140200","article-title":"Melatonin, an endogenous-specific inhibitor of estrogen receptor alpha via calmodulin","volume":"279","author":"Del R\u00edo","year":"2004","journal-title":"Journal of Biological Chemistry"},{"issue":"4","key":"10.1002\/14651858.CD010145.pub2-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"230","DOI":"10.4254\/wjh.v6.i4.230","article-title":"Melatonin attenuates cisplatin-induced HepG2 cell death via the regulation of mTOR and ERCC1 expressions","volume":"6","author":"Bennukul","year":"2014","journal-title":"World Journal of Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD010145.pub2-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"511","DOI":"10.2174\/0109298673262122231011172100","article-title":"Melatonin in chemo\/radiation therapy; implications for normal tissues sparing and tumor suppression: an updated review","volume":"32","author":"Gupta","year":"2025","journal-title":"Current Medicinal Chemistry"},{"issue":"3","key":"10.1002\/14651858.CD010145.pub2-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s10552-023-01806-8","article-title":"Community-engaged basic science in an NCI-designated comprehensive cancer center: antioxidants and chemotherapeutic efficacy","volume":"35","author":"Bollino","year":"2024","journal-title":"Cancer Causes & Control"},{"issue":"4","key":"10.1002\/14651858.CD010145.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1600-079X.2005.00258.x","article-title":"Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and meta-analysis","volume":"39","author":"Mills","year":"2005","journal-title":"Journal of Pineal Research"},{"issue":"5","key":"10.1002\/14651858.CD010145.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ctrv.2007.01.005","article-title":"Impact of antioxidant supplementation on chemotherapeutic efficacy: a systematic review of the evidence from randomized controlled trials","volume":"33","author":"Block","year":"2007","journal-title":"Cancer Treatment Reviews"},{"issue":"3","key":"10.1002\/14651858.CD010145.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10549-008-0193-0","article-title":"Use of antioxidant supplements during breast cancer treatment: a comprehensive review","volume":"115","author":"Greenlee","year":"2009","journal-title":"Breast Cancer Research and Treatment"},{"issue":"19","key":"10.1002\/14651858.CD010145.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.2174\/092986710791233689","article-title":"Clinical uses of melatonin: evaluation of human trials","volume":"17","author":"S\u00e1nchez-Barcel\u00f3","year":"2010","journal-title":"Current Medicinal Chemistry"},{"issue":"9","key":"10.1002\/14651858.CD010145.pub2-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"e060912","DOI":"10.1136\/bmjopen-2022-060912","article-title":"Effect of melatonin on quality of life and symptoms in patients with cancer: a systematic review and meta-analysis of randomised controlled trials","volume":"12","author":"Rongrong","year":"2022","journal-title":"BMJ Open"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.sleep.2021.03.040","article-title":"The effect of melatonin on sleep quality and insomnia in patients with cancer: a systematic review study","volume":"82","author":"Azar","year":"2021","journal-title":"Sleep Medicine"},{"issue":"6","key":"10.1002\/14651858.CD010145.pub2-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.3390\/pharmaceutics15061616","article-title":"Therapeutic potential of melatonin counteracting chemotherapy-induced toxicity in breast cancer patients: a systematic review","volume":"15","author":"Ramos","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0047|cit47","unstructured":"Higgins JP Lasserson T Thomas J Flemyng E Churchill R Methodological expectations of Cochrane intervention reviews. Cochrane: London Available from https:\/\/community.cochrane.org\/mecir-manual"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0049|cit49","unstructured":"National Cancer Institute Definition of anticancer therapy, NCI Dictionary of Cancer Terms https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/anticancer-therapy"},{"issue":"1","key":"10.1002\/14651858.CD010145.pub2-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s41687-020-00244-3","article-title":"Core outcome sets in cancer and their approaches to identifying and selecting patient-reported outcome measures: a systematic review","volume":"4","author":"Ramsey","year":"2020","journal-title":"Journal of Patient-Reported Outcomes"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ejca.2022.10.026","article-title":"Content validity of the EORTC quality of life questionnaire QLQ-C30 for use in cancer","volume":"178","author":"Cocks","year":"2023","journal-title":"European Journal of Cancer (Oxford, England: 1990)"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ejca.2016.08.024","article-title":"The use of EORTC measures in daily clinical practice-a synopsis of a newly developed manual","volume":"68","author":"Wintner","year":"2016","journal-title":"European Journal of Cancer (Oxford, England: 1990)"},{"issue":"3","key":"10.1002\/14651858.CD010145.pub2-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","article-title":"The Functional Assessment of Cancer Therapy scale: development and validation of the general measure","volume":"11","author":"Cella","year":"1993","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0054|cit54","unstructured":"FACIT Searchable Library and Custom Form Developer (Build-a-PRO) https:\/\/wizard.facit.org\/"},{"issue":"2","key":"10.1002\/14651858.CD010145.pub2-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatry Research"},{"issue":"12","key":"10.1002\/14651858.CD010145.pub2-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s40263-019-00680-w","article-title":"Adverse events associated with melatonin for the treatment of primary or secondary sleep disorders: a systematic review","volume":"33","author":"Besag","year":"2019","journal-title":"CNS Drugs"},{"issue":"12","key":"10.1002\/14651858.CD010145.pub2-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1080\/14740338.2022.2160444","article-title":"Adverse events in long-term studies of exogenous melatonin","volume":"21","author":"Besag","year":"2022","journal-title":"Expert Opinion on Drug Safety"},{"issue":"1","key":"10.1002\/14651858.CD010145.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"issue":"3","key":"10.1002\/14651858.CD010145.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0060|cit60","unstructured":"National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0061|cit61","unstructured":"Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from https:\/\/training.cochrane.org\/handbook\/archive\/v5.1\/"},{"issue":"7","key":"10.1002\/14651858.CD010145.pub2-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1080\/09291016.2021.1899485","article-title":"Daily evening melatonin prolongs survival among patients with advanced non-small-cell lung cancer","volume":"53","author":"Hrushesky","year":"2022","journal-title":"Biological Rhythm Research,"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0063|cit63","doi-asserted-by":"crossref","unstructured":"Levin RD Grutsch JF Lis CG Gupta D Wood PA Hrushesky WJ A randomized, double-blind, multicenter trial evaluating the chronotherapeutic role of concomitant melatonin in the treatment of stage IIIB and IV non-small cell lung carcinoma. [Abstract] Proceedings of the 104th Annual Meeting of the American Association for Cancer Research 8 Suppl Abstract nr 4673 10.1158\/1538-7445.AM2013-4673","DOI":"10.1158\/1538-7445.AM2013-4673"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0064|cit64","unstructured":"The survival and quality of life benefits of melatonin when administered to cancer patients at the optimal time of day http:\/\/www.who.int\/trialsearch\/Trial2.aspx?TrialID=ISRCTN16419921"},{"issue":"15","key":"10.1002\/14651858.CD010145.pub2-BIB0065|cit65","first-page":"SUPPL. 1","article-title":"Effect of evening melatonin on the survival of patients with advanced non-small cell lung cancer (ANSCLC)","volume":"32","author":"Lis","year":"2014","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis of clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0067|cit67","unstructured":"Review Manager (RevMan) The Nordic Cochrane Centre, The Cochrane Collaboration 2011"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0068|cit68","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2025"},{"issue":"7414","key":"10.1002\/14651858.CD010145.pub2-BIB0069|cit69","first-page":"557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0070|cit70","unstructured":"GRADE working group GRADEpro: GRADE your evidence and improve your guideline development in health care https:\/\/gradepro.org\/"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0071|cit71","unstructured":"Covidence Veritas Health Innovation 2024"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0072|cit72","unstructured":"Zhao W Effect of the Melatonin plus Chemotherapy on the Immune Function and the Partial Adverse Effects of Chemotherapy of Non-Small Cell Lung Cancer Patients [Thesis] Anhui Medical University 2008"},{"issue":"20","key":"10.1002\/14651858.CD010145.pub2-BIB0073|cit73","first-page":"1658","article-title":"Effects of melatonin plus chemotherapy on the serum concentration of melatonin and the immune funetion of non-small cell lung cancer patients","volume":"17","author":"Zhao","year":"2010","journal-title":"Chinese Journal of Cancer Prevention and Treatment"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0074|cit74","article-title":"Effect of melatonin on early postoperative cognitive dysfunction in elderly patients undergoing gastrointestinal tumor surgery","volume":"null","author":"Hu","year":"2023","journal-title":"Nanchang University"},{"issue":"1","key":"10.1002\/14651858.CD010145.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12904-020-00669-z","article-title":"Melatonin to prevent delirium in patients with advanced cancer: a double blind, parallel, randomized, controlled, feasibility trial","volume":"19","author":"Lawlor","year":"2020","journal-title":"BMC Palliative Care"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0076|cit76","unstructured":"The preventative role of exogenous melatonin administration in patients with advanced cancer who are at risk of delirium: a feasibility study NCT02200172"},{"issue":"6","key":"10.1002\/14651858.CD010145.pub2-BIB0077|cit77","first-page":"NP11","article-title":"Randomised double blind placebo controlled phase ii trial of prolonged release melatonin for prevention of delirium in inpatients with advanced cancer","volume":"Conference: 9th","author":"Agar","year":"2016","journal-title":"Palliative Medicine"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0078|cit78","unstructured":"Melatonin versus placebo for prevention of delirium in inpatients with advanced cancer http:\/\/www.who.int\/trialsearch\/Trial2.aspx?TrialID=ACTRN12612000931875"},{"issue":"1 Supplement 1","key":"10.1002\/14651858.CD010145.pub2-BIB0079|cit79","first-page":"S128","article-title":"Randomised double blind placebo controlled phase II trial of prolonged release melatonin for prevention of delirium in inpatients with advanced cancer","volume":"Australia. 24","author":"Agar","year":"2016","journal-title":"2016 MASCC\/ISOO Annual Meeting on Supportive Care in Cancer."},{"issue":"10","key":"10.1002\/14651858.CD010145.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1200\/JCO.2012.43.6766","article-title":"Effects of melatonin on appetite and other symptoms in patients with advanced cancer and cachexia: a double-blind placebo-controlled trial","volume":"31","author":"Del Fabbro","year":"2013","journal-title":"Journal of Clinical Oncology"},{"issue":"S1","key":"10.1002\/14651858.CD010145.pub2-BIB0081|cit81","first-page":"S247","article-title":"The effect of melatonin on appetite and other symptoms in patients with advanced cancer and cachexia: a double-blind placebo controlled trial","volume":"20","author":"Del Fabbro","year":"2012","journal-title":"Abstracts of the 2012 International MASCC\/ISOO Symposium. Supportive Care in Cancer"},{"issue":"2","key":"10.1002\/14651858.CD010145.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jpainsymman.2012.10.038","article-title":"A double-blind placebo-controlled trial of melatonin for appetite in patients with cancer cachexia (TH307-A)","volume":"45","author":"Del Fabbro","year":"2013","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0083|cit83","unstructured":"Melatonin versus placebo and the effect on appetite in advanced cancer patients NCT00513357"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0084|cit84","unstructured":"Fabbro ED Dev R Hui D Palmer JL Bruera E The effect of melatonin on appetite and other symptoms in patients with advanced cancer and cachexia: a double-blind placebo-controlled trial 2012 Annual Meeting of the American Society of Clinical Oncology, ASCO. Chicago, IL United States. 2012 15 SUPPL 1"},{"issue":"15","key":"10.1002\/14651858.CD010145.pub2-BIB0085|cit85","doi-asserted-by":"publisher","first-page":"TPS319","DOI":"10.1200\/jco.2010.28.15_suppl.tps319","article-title":"A randomized placebo-controlled trial of melatonin for poor appetite in advanced cancer patients","volume":"28","author":"Del Fabbro","year":"2010","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0086|cit86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.eujim.2020.101065","article-title":"The effect of melatonin on cisplatin-induced nephrotoxicity: A pilot, randomized, double-blinded, placebo-controlled clinical trial","volume":"34","author":"Ghadrdan","year":"2020","journal-title":"European Journal of Integrative Medicine"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0087|cit87","unstructured":"Evaluation of nephroprotective effects of Melatonin http:\/\/www.who.int\/trialsearch\/Trial2.aspx?TrialID=IRCT20171225038073N1 2018"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0088|cit88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/15347354231168624","article-title":"A randomized, controlled, parallel-group, trial on the long-term effects of melatonin on fatigue associated with breast cancer and its adjuvant treatments","volume":"22","author":"Sedighi Pashaki","year":"2023","journal-title":"Integrative Cancer Therapies"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0089|cit89","unstructured":"Effect of melatonin drug in decreasing fatigue caused by radiotherapy and chemotherapy IRCT20180426039421N1"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0090|cit90","unstructured":"Follow up of Effects of Melatonin on Fatigue Associated associated with radiotherapy and chemotherapy IRCT20180426039421N3"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1534735420988343","article-title":"A Randomized, controlled, parallel-group, trial on the effects of melatonin on fatigue associated with breast cancer and Its adjuvant treatments","volume":"20","author":"Sedighi Pashaki","year":"2021","journal-title":"Integrative Cancer Therapies"},{"issue":"4","key":"10.1002\/14651858.CD010145.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"23","DOI":"10.30699\/ijbd.13.4.23","article-title":"Effects of melatonin on IL-6 serum level changes and fatigue caused by adjuvant chemoradiotherapy in breast cancer women: a randomized controlled Trial","volume":"13","author":"Sedighi Pashaki","year":"2021","journal-title":"Iranian Journal of Breast Diseases"},{"issue":"Supplement 1","key":"10.1002\/14651858.CD010145.pub2-BIB0093|cit93","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.1016\/S0960-9776(23)00712-9","article-title":"A randomized, controlled, parallel-group, trialon the long-term effects of melatonin on fatigue associated with breast cancer and its adjuvant treatments","volume":"71","author":"Seyed Alireza","year":"2023","journal-title":"Breast"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0094|cit94","doi-asserted-by":"publisher","first-page":"153473542412375","DOI":"10.1177\/15347354241237520","article-title":"The effect of melatonin on increasing the health related quality of life in non-metastatic breast cancer patients: three-year follow up a clinical trial","volume":"23","author":"Keshtpour Amlashi","year":"2024","journal-title":"Integrative Cancer Therapies"},{"issue":"1 Supplement 4","key":"10.1002\/14651858.CD010145.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"101357","DOI":"10.1016\/j.esmoop.2023.101357","article-title":"The long-term melatonin administration and cancer fatigue in breast cancer patients: A randomized, controlled, parallel-group, clinical trial","volume":"8","author":"Javadinia","year":"2023","journal-title":"ESMO Open"},{"issue":"3-4","key":"10.1002\/14651858.CD010145.pub2-BIB0096|cit96","first-page":"188","article-title":"Melatonin for prevention of breast radiation dermatitis: a phase II, prospective, double-blind randomized trial","volume":"18","author":"Ben-David","year":"2016","journal-title":"Israel Medical Association Journal"},{"issue":"0250-7005, 2C","key":"10.1002\/14651858.CD010145.pub2-BIB0097|cit97","first-page":"1951","article-title":"Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan aloneversus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations","volume":"23","author":"Cerea","year":"2003","journal-title":"Anticancer Research"},{"issue":"1","key":"10.1002\/14651858.CD010145.pub2-BIB0098|cit98","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s43046-020-0021-0","article-title":"Effect of melatonin supplementation in combination with neoadjuvant chemotherapy to miR-210 and CD44 expression and clinical response improvement in locally advanced oral squamous cell carcinoma: a randomized controlled trial","volume":"32","author":"Kartini","year":"2020","journal-title":"Journal of the Egyptian National Cancer Institute"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0099|cit99","unstructured":"Melatonin effect in combination with neoadjuvant chemotherapy to clinical response in locally advanced oral squamous cell carcinoma https:\/\/clinicaltrials.gov\/show\/NCT04137627"},{"issue":"1","key":"10.1002\/14651858.CD010145.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4103\/jcar.JCar_19_20","article-title":"Melatonin effect on hypoxia inducible factor-1a and clinical response in patients with oral squamous cell carcinoma receiving neoadjuvant chemotherapy: a randomized controlled trial","volume":"20","author":"Kartini","year":"2021","journal-title":"Journal of Carcinogenesis"},{"issue":"3","key":"10.1002\/14651858.CD010145.pub2-BIB0101|cit101","first-page":"304","article-title":"Impact of melatonin on toxicity and side effect after chemotherapy in elderly non-small cell lung cancer patients","volume":"25","author":"Li","year":"2010","journal-title":"Journal of Practical Oncology"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0102|cit102","first-page":"336","article-title":"Randomized study with the pineal hormone melatonin versus supportive care alone in advanced non-small cell lung cancer resistant to a first-line chemotherapy containing cisplatin","volume":"49","author":"Lissoni","year":"1992","journal-title":"Oncology"},{"issue":"1","key":"10.1002\/14651858.CD010145.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/bjc.1994.34","article-title":"A randomised study with subcutaneous low-dose interleukin 2 alone vs interleukin 2 plus the pineal neurohormone melatonin in advanced solid neoplasms other than renal cancer and melanoma","volume":"69","author":"Lissoni","year":"1994","journal-title":"British Journal of Cancer"},{"issue":"5","key":"10.1002\/14651858.CD010145.pub2-BIB0104|cit104","first-page":"871","article-title":"A randomized study of tamoxifen alone versus tamoxifen plus melatonin in estrogen receptor-negative heavily pretreated metastatic breast-cancer patients","volume":"2","author":"Lissoni","year":"1995","journal-title":"Oncology Reports"},{"issue":"0742-3098, 4","key":"10.1002\/14651858.CD010145.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1600-079X.1996.tb00292.x","article-title":"Adjuvant therapy with the pineal hormone melatonin in patients with lymph node relapse due to malignant melanoma","volume":"21","author":"Lissoni","year":"1996","journal-title":"Journal of Pineal Research"},{"issue":"1","key":"10.1002\/14651858.CD010145.pub2-BIB0106|cit106","first-page":"43","article-title":"Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy alone","volume":"53","author":"Lissoni","year":"1996","journal-title":"Oncology"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF01358887","article-title":"Prevention of cytokine-induced hypotension in cancer patients by the pineal hormone melatonin","volume":"4","author":"Lissoni","year":"1996","journal-title":"Supportive Care in Cancer"},{"issue":"2","key":"10.1002\/14651858.CD010145.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/BF01262569","article-title":"Treatment of cancer chemotherapy-induced toxicity with the pineal hormone melatonin","volume":"5","author":"Lissoni","year":"1997","journal-title":"Supportive Care in Cancer"},{"issue":"1","key":"10.1002\/14651858.CD010145.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1600-079X.1997.tb00329.x","article-title":"A randomized study of chemotherapy with cisplatin plus etoposide versus chemoendocrine therapy with cisplatin, etoposide and the pineal hormone melatonin as a first-line treatment of advanced non-small cell lung cancer patients in a poor clinical state","volume":"23","author":"Lissoni","year":"1997","journal-title":"Journal of Pineal Research"},{"issue":"3","key":"10.1002\/14651858.CD010145.pub2-BIB0110|cit110","first-page":"169","article-title":"Long-term results of cancer immunotherapy with subcutaneous low-dose interleukin-2 plus melatonin","volume":"14","author":"Lissoni","year":"1998","journal-title":"International Journal of Immunotherapy"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/S0959-8049(99)00159-8","article-title":"Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status","volume":"35","author":"Lissoni","year":"1999","journal-title":"European Journal of Cancer"},{"issue":"0302-2838, 1","key":"10.1002\/14651858.CD010145.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000020263","article-title":"Abrogation of the negative influence of opioids on IL-2 immunotherapy of renal cell cancer by melatonin","volume":"38","author":"Lissoni","year":"2000","journal-title":"European Urology"},{"issue":"2","key":"10.1002\/14651858.CD010145.pub2-BIB0113|cit113","first-page":"110","article-title":"Is there a role for melatonin in supportive care?","volume":"10","author":"Lissoni","year":"2002","journal-title":"Support Care Cancer"},{"issue":"2","key":"10.1002\/14651858.CD010145.pub2-BIB0114|cit114","first-page":"110","article-title":"Is there a role for melatonin in supportive care?","volume":"10","author":"Lissoni","year":"2002","journal-title":"Support Care Cancer"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1034\/j.1600-079X.2003.00032.x","article-title":"Five years survival in metastatic non-small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trial","volume":"35","author":"Lissoni","year":"2003","journal-title":"Journal of Pineal Research"},{"issue":"3-4","key":"10.1002\/14651858.CD010145.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.patbio.2006.12.008","article-title":"Biochemotherapy with immunomodulating pineal hormones other than melatonin: 5-methoxytryptamine as a new oncostatic pineal agent","volume":"55","author":"Lissoni","year":"2007","journal-title":"Pathology Biology (Paris)"},{"issue":"3-4","key":"10.1002\/14651858.CD010145.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.patbio.2006.12.025","article-title":"Biochemotherapy with standard chemotherapies plus the pineal hormone melatonin in the treatment of advanced solid neoplasms","volume":"55","author":"Lissoni","year":"2007","journal-title":"Pathology Biology (Paris)"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0118|cit118","first-page":"1377","article-title":"Neuroimmunomodulation in medical oncology: application of psychoneuroimmunology with subcutaneous low-dose IL-2 and the pineal hormone melatonin in patients with untreatable metastatic solid tumors","volume":"28","author":"Lissoni","year":"2008","journal-title":"Anticancer Research"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1007\/s12094-021-02586-w","article-title":"Randomized placebo-controlled phase II trial of high-dose melatonin mucoadhesive oral gel for the prevention and treatment of oral mucositis in patients with head and neck cancer undergoing radiation therapy concurrent with systemic treatment","volume":"23","author":"Lozano","year":"2021","journal-title":"Clinical & Translational Oncology"},{"issue":"2, Suppl 1","key":"10.1002\/14651858.CD010145.pub2-BIB0120|cit120","first-page":"S136","article-title":"Melatonin oral gel for the prevention of severe oral mucositis H and N cancer undergoing chemo\/bio radiation (Mucomel)","volume":"25 RTY - Journa","author":"Tarrago","year":"2017","journal-title":"2017 International MASCC\/ISOO Symposium: Supportive Care in Cancer. United States."},{"key":"10.1002\/14651858.CD010145.pub2-BIB0121|cit121","unstructured":"Melatonin oral gel for oral mucositis in patients with head and neck cancer undergoing chemoradiation https:\/\/clinicaltrials.gov\/study\/NCT02630004"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0122|cit122","doi-asserted-by":"crossref","unstructured":"Lozano A Marruecos J Rubio-Casadevall J Farre N Lopez-Pousa A Giralt J Phase II trial of high-dose melatonin oral gel for the prevention and treatment of oral mucositis in H&N cancer patients undergoing chemoradiation (MUCOMEL) 2018 Annual Meeting of the American Society of Clinical Oncology, ASCO 2018. United States 2018 15, Suppl 1","DOI":"10.1200\/JCO.2018.36.15_suppl.6007"},{"issue":"5","key":"10.1002\/14651858.CD010145.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/onco.13761","article-title":"Melatonin and metformin failed to modify the effect of dacarbazine in melanoma","volume":"26","author":"Novik","year":"2021","journal-title":"Oncologist"},{"issue":"2","key":"10.1002\/14651858.CD010145.pub2-BIB0124|cit124","first-page":"324","article-title":"The first results of assessment of clinical efficacy of melatonin and metformin in patients with disseminated skin melanoma receiving dacarbazine as first-fine systemic therapy","volume":"62","author":"Novik","year":"2016","journal-title":"Voprosy Onkologii"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0125|cit125","unstructured":"Comparison of melatonin or metformin and dacarbazine combination versus dacarbazine alone in disseminated melanoma https:\/\/clinicaltrials.gov\/study\/NCT02190838"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0126|cit126","unstructured":"Adjuvant melatonin for prevention of lung cancer recurrence and mortality https:\/\/clinicaltrials.gov\/study\/NCT00668707"},{"issue":"100763","key":"10.1002\/14651858.CD010145.pub2-BIB0127|cit127","first-page":"1","article-title":"Adjuvant melatonin for the prevention of recurrence and mortality following lung cancer resection (AMPLCaRe): a randomized placebo controlled clinical trial","volume":"33","author":"Seely","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"5","key":"10.1002\/14651858.CD010145.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"612","DOI":"10.37469\/0507-3758-2018-64-5-612-619","article-title":"Melatonin and metformin in neoadjuvant hormonotherapy in locally advanced breast cancer","volume":"64","author":"Semiglazova","year":"2018","journal-title":"Voprosy Onkologii"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0129|cit129","unstructured":"Neoadjuvant toremifene with melatonin or metformin in locally advanced breast cancer https:\/\/clinicaltrials.gov\/study\/NCT02506790"},{"issue":"Supl.5","key":"10.1002\/14651858.CD010145.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"v99","DOI":"10.1093\/annonc\/mdz241.002","article-title":"Neoadjuvant endocrine therapy in combination with melatonin and metformin in locally advanced breast cancer","volume":"30","author":"Semiglazova","year":"2019","journal-title":"Annals of Oncology"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0131|cit131","unstructured":"Neoadjuvant FDC with melatonin or metformin for locally advanced breast cancer https:\/\/clinicaltrials.gov\/study\/NCT02506777"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"v100","DOI":"10.1093\/annonc\/mdz241.003","article-title":"Melatonin and metformin in neoadjuvant chemotherapy in locally advanced breast cancer","volume":"30","author":"Semiglazova","year":"2019","journal-title":"Annals of Oncology"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0133|cit133","unstructured":"Melatonin in reduction of chemotherapy-induced toxicity (MIRCIT) trial https:\/\/clinicaltrials.gov\/study\/NCT01706627"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0134|cit134","first-page":"7323","article-title":"Melatonin in patients with cancer receiving chemotherapy: a randomized, double-blind, placebo-controlled trial","volume":"34","author":"Sookprasert","year":"2014","journal-title":"Anticancer Research"},{"issue":"1","key":"10.1002\/14651858.CD010145.pub2-BIB0135|cit135","doi-asserted-by":"publisher","first-page":"e12840","DOI":"10.1111\/jpi.12840","article-title":"Quality-of-life outcomes following topical melatonin application against acute radiation dermatitis in patients with early breast cancer: a double-blind, randomized, placebo-controlled trial","volume":"74","author":"Zetner","year":"2022","journal-title":"Journal of Pineal Research"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0136|cit136","unstructured":"MELADERM-trial: melatonin cream against acute radiation dermatitis in patients with breast cancer https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2018-001705-91\/DK"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0137|cit137","unstructured":"Melatonin cream against acute radiation dermatitis in patients with early breast cancer https:\/\/clinicaltrials.gov\/study\/NCT03716583"},{"issue":"1","key":"10.1002\/14651858.CD010145.pub2-BIB0138|cit138","doi-asserted-by":"publisher","first-page":"e12873","DOI":"10.1111\/jpi.12873","article-title":"Effect of melatonin cream on acute radiation dermatitis in patients with primary breast cancer: a double-blind, randomized, placebo-controlled trial","volume":"75","author":"Zetner","year":"2023","journal-title":"Journal of Pineal Research"},{"issue":"2","key":"10.1002\/14651858.CD010145.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1034\/j.1600-079X.2001.300208.x","article-title":"Thrombopoietic properties of 5-methoxytryptamine plus melatonin versus melatonin alone in the treatment of cancer-related thrombocytopenia","volume":"30","author":"Lissoni","year":"2001","journal-title":"Journal of Pineal Research"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1749-6632.2000.tb05421.x","article-title":"Modulation of anticancer cytokines IL-2 and IL-12 by melatonin and the other pineal indoles 5-methoxytryptamine and 5-methoxytryptophol in the treatment of human neoplasms","volume":"917","author":"Lissoni","year":"2000","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0141|cit141","unstructured":"Seely D Wu P Fritz H Kennedy DA Tsui T Seely AJ Melatonin as adjuvant cancer care with and without chemotherapy: a systematic review and meta-analysis of randomized trials Integrative Cancer Therapies"},{"issue":"5","key":"10.1002\/14651858.CD010145.pub2-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s00280-012-1828-8","article-title":"The efficacy and safety of melatonin in concurrent chemotherapy or radiotherapy for solid tumors: a meta-analysis of randomized controlled trials","volume":"69","author":"Wang","year":"2012","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"10.1002\/14651858.CD010145.pub2-BIB0143|cit143","doi-asserted-by":"publisher","first-page":"7895","DOI":"10.2147\/OTT.S174100","article-title":"Therapeutic strategies of melatonin in cancer patients: a systematic review and meta-analysis","volume":"11","author":"Wang","year":"2018","journal-title":"OncoTargets and Therapy"},{"issue":"1","key":"10.1002\/14651858.CD010145.pub2-BIB0144|cit144","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4172\/1948-5956.1000577","article-title":"The role of melatonin in improving clinical responses of chemotherapy in solid cancer patients: a systematic review","volume":"11","author":"Kartini","year":"2019","journal-title":"Journal of Cancer Science & Therapy"},{"issue":"10","key":"10.1002\/14651858.CD010145.pub2-BIB0145|cit145","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010145","article-title":"Melatonin in cancer treatment","author":"Wolf","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:32:43Z","timestamp":1787581963000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010145.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":145,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010145.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,30]]}}}